13 Best Pharma Dividend Stocks To Buy in 2024 - Insider Monkey

Mar 5, 2024 · This was the company’s 12th consecutive year of dividend growth, which places ZTS on our list of the best pharma dividend stocks to buy in 2024. The stock has a dividend …

CouponFollow Extension

$0.43
OFF

13 Best Pharma Dividend Stocks To Buy In 2024 - InvestingChannel

3 weeks from now

Mar 5, 2024 · On February 6, the company announced a quarterly dividend of $0.432 per share, which fell in line with its previous dividend. This was the company’s 12th consecutive year of …

investingchannel.com

FAQs about 13 Best Pharma Dividend Stocks To Buy in 2024 - Insider Monkey Coupon?

Should you buy Pharma dividend stocks in 2024?

Overall PFE ranks 5th on our list of the best pharma dividend stocks to buy in 2024. While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. ...

Is Pfizer (PFE) a good dividend stock?

It offers medicines and vaccines across multiple therapeutic areas, including cardiovascular, women's health, and infectious diseases, with key brands like Eliquis, Nurtec ODT/Vydura, and the Prevnar family. Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to consider. ...

Is Gilead Sciences (Gild) a good stock to buy in 2024?

Gilead Sciences, Inc. (NASDAQ:GILD) is a popular pharma name among Wall Street hedge funds. At the end of Q3 2024, 59 hedge funds were bullish on Gilead Sciences, Inc. (NASDAQ:GILD), compared to 62 in the last quarter. Overall GILD ranks 13th on our list of the best pharma dividend stocks to buy in 2024. ...

Is Novo Nordisk a good dividend stock?

The company offers treatments for diabetes, obesity, cardiovascular conditions, rare blood and endocrine disorders, and hormone replacement therapy. Novo Nordisk A/S (NYSE:NVO) ranks 11th on our list of the best dividend stocks. ...

How much money does a pharmaceutical company make in 2023?

According to S&P Global Ratings, major pharmaceutical companies collectively earned around $700 billion in revenue during 2023, which includes some additional revenue sources beyond pharmaceuticals. This amount constitutes over half of the estimated $1.1 trillion global pharmaceutical market. ...

Is Gilead Sciences (Gild) a good dividend stock?

On November 7, Gilead Sciences, Inc. (NASDAQ:GILD) declared a $0.77 per share quarterly dividend. The dividend is distributable on December 30, to shareholders on record as of December 13. It is one of the best dividend stocks to invest in. Gilead Sciences, Inc. (NASDAQ:GILD) is a popular pharma name among Wall Street hedge funds. ...